STX-0119, with the CAS number 851095-32-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective antagonist of certain receptors, which may play a role in various biological pathways. The compound's structure typically features specific functional groups that contribute to its biological activity and pharmacokinetic properties. STX-0119 has been investigated for its effects on neurological conditions, and its mechanism of action involves modulation of neurotransmitter systems. As with many compounds in drug development, its efficacy, safety, and potential side effects are subjects of ongoing research. Understanding the characteristics of STX-0119, including its solubility, stability, and interaction with biological targets, is crucial for evaluating its therapeutic potential and guiding future studies.

STX-0119

851095-32-4: STX-0119, with the CAS number 851095-32-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective antagonist of certain receptors, which may play a role in various biological pathways. The compound's structure typically features specific functional groups that contribute to its biological activity and pharmacokinetic properties. STX-0119 has been investigated for its effects on neurological conditions, and its mechanism of action involves modulation of neurotransmitter systems. As with many compounds in drug development, its efficacy, safety, and potential side effects are subjects of ongoing research. Understanding the characteristics of STX-0119, including its solubility, stability, and interaction with biological targets, is crucial for evaluating its therapeutic potential and guiding future studies.

<p>STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an IC50 of 74 μM.</p>

CAS 851095-32-4

STX-0119

STX-0119

Ref: TM-T60160

STX-0119

Ref: 54-BUP13246

N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide

Ref: TR-F863670